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The World Health Organisation 1 defines rehabilitation as Ba set of measures that assist individuals who experience, or are likely to experience, disability to achieve and maintain optimal functioning in interaction with their environments[. In this context, the maximization of health-related quality of life (HRQoL) is identified as a pivotal goal of an individualized and coordinated rehabilitation approach. Previous studies have demonstrated reduced quality of life after acute stroke, 2Y4 with lower HRQoL outcomes associated with disability, 4Y8 functional status, 3 ,9Y11 depression, 4Y6,10,12 female sex, 4, 5, 7 coping strategies, 5 social support, 2, 5, 7, 11, 12 reduced upper extremity function, 6 baseline stroke severity, 4, 7 baseline neglect, 4 institutionalization, 4 increasing age, 4,10 dementia, 4 education level, 3 low socioeconomic status, 4, 8, 11 and general pain report. 13 The relationship between pain and HRQoL post-stroke has received far less attention. A recent systematic review 14 reported post-stroke upper limb interventions can have an effect on HRQoL, but information specifically regarding the association between hemiplegic shoulder pain (HSP) and HRQoL is lacking. With frequency of approximately 25%, 15 we hypothesize that HSP would specifically and adversely reduce HRQoL as measured at 12 months post-stroke. Lower HRQoL can have a negative impact on mortality, and as such the identification of factors that lower HRQoL is an important focus of intervention.
METHODS

Study Population
This paper represents a secondary analysis of data from the BAdelaide Stroke Incidence Study[ (ASCEND), 16 a prospective population-based study within a geographically defined region of metropolitan Adelaide, with a census-projected population of 148,000. All participants provided written informed consent and the study was approved by the local ethics committee. Multiple methods of case ascertainment were utilized to identify all occurrences of confirmed stroke within a 12-month period. The World Health Organisation (WHO) definition of stroke 17 was used, and all cases of confirmed stroke were included for analysis. Non-traumatic subarachnoid hemorrhages were included, but cases of traumatic hemorrhage or transient ischemia were excluded. 16 The methodology has been previously described, 16 including detailed information regarding ascertainment techniques, participant characteristics, data collection, and storage. After ascertainment and consent, participants were assessed at baseline, and then at 4 and 12 months later. Data collected included demographics, medical and radiological details of the incident stroke, medical history, shoulder pain assessment, and admissions history. Multiple outcome measures were collected at each time point. HSP was identified as an area of interest in the study and attention was paid to accurate measurement at each time point. Subjective measures of HSP included severity, aggravating features, time of onset, and pre-morbid shoulder history.
Outcome Measures
The current analysis focuses on the factors assessed as potential determinants of 12-month HRQoL as measured by the summary index score derived from the descriptive system of EuroQol-5D-3L (EQ). The EQ-5D-3L compromises a visual analogue scale and a 5-dimension descriptive system (dimensions include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). 18 Australian weight EQ-5D-3L summary index (EQindex) score ranges from j0.217 to 1, with death represented by 0, with negative values representing worse than death and full health represented by 1. 1, 19 Baseline variables included age, sex, stroke type (ischemic vs. hemorrhagic), Oxfordshire stroke clinical classification, and baseline stroke severity as measured by the National Institute of Health stroke scale (NIHSS). Hemiplegic shoulder pain (visual analogue scale; VAS 0Y100 mm) and depression (Geriatric Depression Scale; GDS) were measured for each follow-up period as participant pain and depression rating at the time of questioning. Pain and depression were considered continuous predictor (exposure) variables rather than outcome variables and therefore not treated as repeated measurements for multiple linear regression analysis. Scores (VAS, GDS) were calculated as quantitative exposure values and averaged over all follow-up periods. The averaging of repeated continuous exposure variables is seen to reduce measurement error and increase exposure value validity, particularly in the context of prospective cohort studies. 20 Measures of the level of dependency at 12-month follow-up included modified Rankin scale (mRS), any institutionalization (movement into nursing home during the follow-up period), and access to any inpatient rehabilitation over the follow-up period.
Continuous variables of mRS and NIHSS were divided into clinically meaningful categories: mRS was dichotomized into Bindependent 0Y2[ and Bdependent 3Y6[, where a mRS score of 0 is fully independent and a score of 6 is given for death 21 ;
www.ajpmr.com NIHSS was divided into three categories; mild G7, moderate 7Y22, and severe 922. 21 
Statistical Analysis
The outcome variable for the study was EQ index score. The association between each predictor variable with the outcome variable was assessed by two-sample Student t-test (sex, stroke type, any HSP, inpatient rehabilitation, and whether GDS 95) and one-way ANOVA (age, NIHSS).
With the assumption that data were missing at random, we used multiple imputation to impute missing values in the database. The variables used to impute the missing values were age, gender, stroke type, Oxfordshire classification, baseline NIHSS, HSP score, GDS score, and EQ index score. The EQ index was assigned 0 in participants who had died by 12 months. Twenty databases were imputed. Multiple linear regression analysis based on imputed databases was performed to test the association between HSP and HRQoL, controlling all other considered confounders. Sensitivity analyses for the multiple linear regressions were performed by using complete cases in the database (non-imputed dataset) and were compared with dataset from multiple imputation. All data analyses were conducted using SPSS 21 and SAS 9.3.
RESULTS
The dataset of urban participants in ASCEND included 318 cases of stroke among 301 people. Only first-ever cases of stroke within the follow-up period were analyzed for this study (n = 300 with the exclusion of single duplicate case). Figure 1 outlines the sample and available follow-up data. Completeness of data collection varied between follow-up periods and individual cases.
There were 12-month HRQoL data available for 263 participants (87.7%), inclusive of 105 people who died before 12-month follow-up (in these cases, the index score was attributed as 0). The mean 12-month EQ index score was 0.463 (SD 0.435). Table 1 summarizes the association between EQ index scores and each predictor variable. Comparison of the mean EQ index between participants with/ without any HSP over the follow-up period demonstrated lower mean scores in the group reporting HSP compared to those with no pain: 0.572 (0.357) versus 0.725 (0.369), P = 0.017.
Multivariable linear regression analysis demonstrated that increasing exposure scores for HSP (VAS) and depression (GDS), together with stroke severity (NIHSS) and 12-month dependence (mRS), were each independently and significantly associated with lowered HRQoL utility scores at 12 months ( Table 2 ). Absence of access to inpatient rehabilitation after stroke was also associated with lower EQ index scores. Age, sex, stroke type (ischemic vs. hemorrhagic), Oxfordshire classification, and institutionalization during follow-up were not associated with reduced HR-QoL at 12 months.
Sensitivity analysis by comparing results for complete cases and imputed cases of multiple linear regression showed that the association between HSP and EQ index score, association between depression (GDS) and EQ index score, and association between mRS and EQindex score were consistent in terms of unchanged direction and significance (see Appendix; http://links.lww.com/PHM/A221).
DISCUSSION
Our analysis of the ASCEND dataset has shown that HSP reported at any time in the first year after the onset of acute stroke is associated with lower HRQoL. The A value indicates that for every one unit of increased pain on VAS (0Y100 mm), there is an associated 0.011 reduction in QoL score (EQindex). The current analysis treats pain as a continuous variable, without characterizing into pain severity categories. Future studies could offer further insight into the association between clinically accepted pain severities (mild, moderate, severe) and HRQoL.
Koog et al._s cross-sectional survey of 177 rehabilitation stroke outpatients 22 reported high rates of any pain (42%), but pain was not associated with lower HRQoL. However, Widar et al. 11 reviewed 43 selected stroke patients with chronic pain, but not specific to the shoulder, and showed a lower HRQoL score as compared to previous studies, implying that population-based studies were needed to further evaluate the association between pain and HRQoL. The Bergen Stroke Study 13 surveyed 328 surviving patients admitted to a hospital stroke unit, reporting that pain, fatigue, and depression are major contributors to quality of life. One small cross-sectional study 23 outlines specific assessment of HSP and its effect on HRQoL. Chae et al. 23 concluded a statistically significant association between shoulder pain and quality of life, but not between pain and motor impairment or activity limitation, without any adjustment for depression being made. To the best of our knowledge, this is the first ideal 17 populationbased stroke incidence study to include a comprehensive assessment of HSP and showed it to be an independent determinant of subsequent HRQoL. The HRQoL results reveal significant reduction in mean utility scores in a stroke population, in keeping with previous observations. 2Y4 Australian normative HRQoL benchmark data is now available for comparison, with recent research 1 establishing a general population HRQoL mean of 0.87 with a minimal clinically important difference (MCID) of 0.05. This contextualized the current results as a 50% reduction in HRQoL in a stroke population. Mean HRQoL was lower in participants who reported HSP during the follow-up period (participants with HSP: 0.572 (0.357) versus participants without HSP 0.725 (0.369), P = 0.017). The means are observed to be higher than the imputed mean, likely reflecting that completeness of shoulder assessments may have been reduced by overall morbidity.
A comparable Australian population-based study, which was undertaken 10 years ago, 4 used a similar methodology but did not specifically report on the association between pain and HRQoL. That study used the Assessment of Quality of Life instrument (AQoL) 24 and found a mean utility score of 0.47, whereas the mean utility score reported in the current study using the EQ-5D-3L was 0.463. Although indirect comparison of mean HRQoL scores across populations and time is not valid with different assessment measures, and which reflect differing constructs of quality of life, 18 independent determinants of HRQoL are consistent across studies. Both found that higher levels of NIHSS, depression, and disability, along with demographic factors of age and sex, all predicted reduced HRQoL.
A strength of our study is use of a prospective population-based methodology. Moreover, we made adjustment for depression in the statistical analysis model to exclude the expression of pain as a proxy for depression ratings. Limitations are recognized in variable missing data over follow-up, which was overcome to some extent by the use of multiple imputation. The association of pain, depression, and dependence with HRQoL is significant (pooled data P G 0.001 for each). Robustness of this result is demonstrated by comparable significance on sensitivity analysis (see Appendix table) .
CONCLUSION
In summary, HSP seems to reduce HRQoL at 12 months after acute stroke. This finding is important in the context of HSP being a potentially preventable (or reversible) factor. More effort should be directed towards screening and treating this high incidence complication of stroke.
